Molybdenum cofactor deficiency in a Malaysian child
1Clinical Genetic Unit, Paediatric Institute, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur 50586, Malaysia. ngulh@hotmail.com
Singapore Medical Journal
|November 13, 2009
Summary
Molybdenum cofactor deficiency, a rare genetic disorder, causes severe neonatal encephalopathy. Early diagnosis is crucial, as this condition mimics hypoxic-ischaemic insult but has distinct laboratory markers.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Molybdenum cofactor deficiency is a rare, autosomal recessive genetic disorder.
- It presents with severe neurological symptoms, often fatal in infancy, mimicking hypoxic-ischaemic insult.
- Symptoms include neonatal-onset encephalopathy, intractable seizures, and feeding/respiratory issues.
Observation:
- A case of an 8-year-old boy with severe neurological manifestations since birth, but without significant seizures, is presented.
- This presentation highlights the variability in clinical presentation, particularly the absence of seizures.
- The patient's neuroimaging findings were consistent with hypoxic-ischaemic encephalopathy.
Findings:
- Molybdenum cofactor deficiency should be considered in newborns with unexplained encephalopathy and imaging suggestive of hypoxic-ischaemic insult.
- Key diagnostic laboratory findings include low serum uric acid, positive urine sulfite tests, and elevated urinary S-sulfocysteine, hypoxanthine, and xanthine.
- This case underscores the importance of considering rare metabolic disorders in neonatal encephalopathy.
Implications:
- Early identification and diagnosis of molybdenum cofactor deficiency are critical for timely intervention.
- Recognizing this disorder can prevent misdiagnosis as hypoxic-ischaemic insult, allowing for appropriate management.
- This case expands the understanding of the clinical spectrum of molybdenum cofactor deficiency.
Related Concept Videos
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cofactors and Coenzymes
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life


